dementia & alzheimer's:
Personalised Cellular treatment

T-regulatory cells
(T-regs)

T-regulatory cells (T-regs) are specialised immune cells responsible for maintaining immune balance and preventing excessive or destructive inflammatory responses, particularly within the central nervous system.

​

In Dementia and Alzheimer’s Disease, T-regs play a critical role in suppressing chronic neuroinflammatory and microglial overactivation that contributes to neuronal loss, synaptic dysfunction and progressive cognitive decline.

​

At BioCells Medical, T-reg therapy is delivered through a personalised protocol based on either autologous cells (patient-derived) or carefully selected allogeneic cells (donor-derived), depending on clinical indications, immune profile and disease dynamics. The objective is to precisely recalibrate immune regulation and restore long-term neuro-immune stability.

​

Through targeted immune recalibration, T-reg therapy is designed to stop immune-driven functional and cognitive deterioration, stabilise neurological performance and reduce symptom burden such as cognitive fluctuations, behavioural instability, mental fatigue and loss of daily functional independence in selected patients.

Purified concentrated 
exosomes

Purified exosomes are nanoscale biological vesicles naturally released by regenerative cells, containing concentrated growth factors, regulatory proteins and micro-RNAs involved in cellular repair and intercellular communication.

​

In Dementia and Alzheimer’s Disease, exosomes function as molecular messengers that influence key disease-related processes by reducing oxidative stress, modulating neuroinflammatory signaling and supporting metabolic and synaptic activity within vulnerable neural networks.

​

At BioCells Medical, exosomes are produced in our laboratory as highly purified, concentrated formulations, ensuring consistent bioactivity, controlled composition and a high safety profile prior to clinical application.

​

Acting at a molecular level, purified exosomes are designed to interrupt degenerative signaling pathways, enhance synaptic efficiency and metabolic resilience, and support memory processing, cognitive endurance and neurological responsiveness — contributing to measurable cognitive and functional improvement and sustained stability across different stages of Dementia and Alzheimer’s Disease.

Personalised Neurostimulation Therapy

Neurostimulation is a non-invasive medical technology that delivers precisely controlled electrical impulses to targeted regions of the brain and spinal cord.

​

In Dementia and Alzheimer’s Disease, neurostimulation is used to modulate dysfunctional cognitive networks, enhance neural signaling within memory- and attention-related circuits, and improve communication between cortical and subcortical brain regions.

​

At BioCells Medical, neurostimulation is integrated into a personalised therapeutic protocol and applied according to the patient’s neurological profile, cognitive deficits and disease stage, with the goal of optimising neural responsiveness and reinforcing cognitive and functional recovery.

​

By modulating neural circuits and restoring more physiological signaling patterns, neurostimulation aims to stop progressive cognitive and functional decline, improve memory retention, attention, processing speed and executive control, and restore greater mental clarity, daily orientation and functional independence.

Peptide-Based
Protocol

Peptide therapy utilises precisely engineered biological molecules that function as cell-to-cell messengers, restoring disrupted communication within the nervous and immune systems.

In Dementia and Alzheimer’s Disease, targeted peptides are applied to optimise mitochondrial function, support cellular energy production and protein synthesis, and regulate metabolic and inflammatory pathways that contribute to neuronal stress, synaptic dysfunction and cognitive decline.

At BioCells Medical, peptide therapy is incorporated into a personalised therapeutic plan through custom-tailored formulations, selected according to the patient’s metabolic profile, neurological status and disease stage, with the objective of reinforcing long-term neuroprotective and metabolic stability.

By optimising cellular signaling and energy regulation, peptide therapy aims to stop metabolic-driven cognitive and functional decline, reduce mental fatigue, enhance cognitive clarity and endurance, and maintain sustained energy balance — strengthening overall neurological performance and daily functional capacity.